Gala Global (539228)
Asset PlayScore breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹3.43 |
| Market Cap | ₹19.47 Cr |
| P/E Ratio | 0 |
| ROCE | -1.82% |
| ROE | -19.78% |
| Dividend Yield | 0% |
| Profit Growth | -783.33% |
| Debt/Equity | — |
| Sales Growth | 21.1% |
| 52-Week Range | ₹1.1 — ₹3.43 |
| Sector | Household Products |
| Book Value | ₹9 |
Strengths
- Price is only 38% of stated book value: ₹3.43 versus ₹9.00 per share.
- Sales growth of 21.10% shows the business still has some operating activity.
- Latest quarter sales of ₹9 Cr indicate a continuing enterprise, not a shell.
- Market cap of ₹19 Cr is small, so even a modest business improvement could move the stock significantly.
Concerns
- ROE is deeply negative at -19.78%, indicating shareholder capital is being destroyed.
- ROCE of -1.82% shows the company is not earning an acceptable return on capital.
- Profit growth of -783.33% and a latest quarter net profit of ₹-0 Cr reveal no real earnings power.
- Piotroski F-Score of 3/9 suggests weak financial health, with no dividend and incomplete debt/promoter disclosures.
AI Analysis
Looking at Gala Global, the first thing that catches my eye is the price-to-book ratio of 0.38. At ₹3.43 against a book value of ₹9, the market is giving me a rupee of stated equity for 38 paise. Ben Graham would call this a bargain, but he would first ask: is that book value real? Here, the evidence is disturbing. Return on equity is minus 19.78%, and return on capital employed is minus 1.82%. That means this book value is not working; it is shrinking. The business is burning shareholder capital, and a low P/B ratio is not a bargain if the enterprise keeps losing money. Sales grew 21.10%, but profit growth collapsed by 783.33%. That is growth of the wrong kind. The latest quarter shows sales of only ₹9 Cr with essentially no net profit, so even a promising topline has not translated into earnings. The Piotroski F-Score of 3/9 reinforces my concern: weak profitability and weak financial health. With no dividend, zero return for waiting, and debt/equity not available, the picture is murky. Promoter holding is not disclosed either—if owners do not publicly stand behind the company, I grow even more cautious. This is not a quality business; there is no moat I can see in stationary. It is a balance-sheet speculation. At ₹19 Cr market cap versus a stated equity near ₹50 Cr, it could be an asset play, but only if those book assets can be realised or redeployed. In the meantime, negative ROE is destroying value. I would not buy unless I saw a credible path to positive earnings and honest disclosures on debt and promoter ownership. A cheap stock that earns nothing is a trap unless something changes.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer